Who invested in Cytomics Pharmaceuticals?
Cytomics Pharmaceuticals's investors include Edmond de Rothschild Venture Capital, Truffle Capital and SG Asset Management Private Equity.
France · Series B startup
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2006, from 1 source
Cytomics Pharmaceuticals's investors include Edmond de Rothschild Venture Capital, Truffle Capital and SG Asset Management Private Equity.
Cytomics Pharmaceuticals has raised $12M across 1 round since 2006.
Cytomics Pharmaceuticals's most recent round was a Series B of $12M in Feb 2006.
Its most recent round, $12M in Feb 2006, is also its largest on record.
Cytomics Pharmaceuticals's first round on record, in Feb 2006, was backed by Edmond de Rothschild Venture Capital, Truffle Capital and SG Asset Management Private Equity.
Cytomics Pharmaceuticals's latest named round is a Series B, in Feb 2006.
Cytomics Pharmaceuticals is based in France.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.